COST-EFFECTIVENESS ANALYSIS OF DIFELIKEFALIN FOR THE TREATMENT OF CHRONIC KIDNEY DISEASE ASSOCIATED-PRURITUS IN SPAIN

被引：0
|
作者：
Sanchez-Alvarez, Emilio E.
Poveda, J. L. [1 ]
Sanchez-Villanueva, R. [2 ]
Ramirez, de Arellano Serna A. [3 ]
Olga, R. [3 ]
De, La Paz Canizares I. [4 ]
Hernaez Colque, M. [5 ]
机构：
[1] Hosp Univ & Politecn La Fe, Valencia, Spain
[2] La Paz Hosp, Madrid, Spain
[3] CSL Vifor, Glattbrugg, ZH, Switzerland
[4] Alira Hlth, Barcelona, Spain
[5] Alira Hlth, Madrid, Spain
来源：
VALUE IN HEALTH | 2024年 / 27卷 / 12期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
EE364
引用
收藏
页码：S126 / S126
页数：1
相关论文
共 50 条
  • [31] Cost-effectiveness of sodium zirconium cyclosilicate for the treatment of hyperkalemia in patients with chronic kidney disease or heart failure in Spain
    Alcazar-Arroyo, Roberto
    Crespo-Leiro, Maria G.
    Bover, Jordi
    Oliva, Juan
    Sequera-Mutiozabal, Miren
    Gradari, Simona
    Marinez-Lopez, Anisia
    Lopez-Chicheri, Blanca
    Vidal-Vilar, Neus
    Aceituno, Susana
    Cobo, Marta
    NEFROLOGIA, 2024, 44 (05): : 709 - 720
  • [32] Use of surrogacy for women with chronic kidney disease: a cost-effectiveness analysis
    Farwell, Jennifer
    Wyatt, Solange
    Rueda, Jose
    Emerson, Jenna
    Page, Jessica
    Fowler, Jessica
    Allen, Allison
    Caughey, Aaron
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2013, 208 (01) : S153 - S153
  • [33] TIME TO IMPROVEMENT OF ITCH INTENSITY IN PATIENTS WITH CHRONIC KIDNEY DISEASE-ASSOCIATED PRURITUS TREATED WITH DIFELIKEFALIN
    Topf, Joel
    Schaufler, Thilo
    Ruessmann, Despina
    Morin, Isabelle
    Wen, Warren
    Menzaghi, Frederique
    Fishbane, Steven
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2023, 81 (04) : S76 - S76
  • [34] TIME TO IMPROVEMENT OF ITCH INTENSITY IN PATIENTS WITH CHRONIC KIDNEY DISEASE-ASSOCIATED PRURITUS TREATED WITH DIFELIKEFALIN
    Csiky, Botond
    Walpen, Sebastian
    Schaufler, Thilo
    Morin, Isabelle
    Wen, Warren
    Menzaghi, Frederique
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2022, 37 : I336 - I337
  • [35] Cost-Effectiveness of Dapagliflozin for Chronic Kidney Disease in Japan
    Kodera, Satoshi
    Morita, Hiroyuki
    Nishi, Hiroshi
    Takeda, Norifumi
    Ando, Jiro
    Komuro, Issei
    CIRCULATION JOURNAL, 2022, 86 (12) : 2021 - +
  • [36] THE COST-EFFECTIVENESS OF PHOSPHATE BINDERS FOR THE TREATMENT OF HYPERPHOSPHATEMIA IN CHRONIC KIDNEY DISEASE (CKD)
    Keith, M. S.
    Carlton, R.
    Meissner, B. L.
    VALUE IN HEALTH, 2009, 12 (07) : A309 - A309
  • [37] COST-EFFECTIVENESS OF ROFLUMILAST (DAXAS®) IN THE TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) IN SPAIN
    Lindner, L.
    Camins de Valdenebro, L.
    Aparicio Martinez, J.
    VALUE IN HEALTH, 2011, 14 (07) : A493 - A493
  • [38] COST-EFFECTIVENESS ANALYSIS OF EMPAGLIFLOZIN FOR ADULTS WITH CHRONIC KIDNEY DISEASE (CKD) IN GREECE
    Koulentaki, M.
    Vlahakos, D.
    Tsimihodimos, V
    Smyrnaios, C.
    Delli, E.
    Karpouzos, G.
    Kourlaba, G.
    VALUE IN HEALTH, 2024, 27 (12) : S75 - S75
  • [39] Population-Wide Screening for Chronic Kidney Disease A Cost-Effectiveness Analysis
    Cusick, Marika M.
    Tisdale, Rebecca L.
    Chertow, Glenn M.
    Owens, Douglas K.
    Goldhaber-Fiebert, Jeremy D.
    ANNALS OF INTERNAL MEDICINE, 2023, 176 (06) : 788 - +
  • [40] A COST-EFFECTIVENESS ANALYSIS OF PATIROMER FOR THE TREATMENT OF HYPERKALEMIA IN SPAIN
    Gonzalez-Juanatey, J. R.
    Gonzalez-Franco, A.
    de-Sequera-Ortiz, P.
    Valls, M.
    Serna, Ramirez de Arellano A.
    Pomares, E.
    Nieves, D.
    VALUE IN HEALTH, 2022, 25 (01) : S94 - S95
12345